Plasma amyloid β protein 1–42 levels are increased in old Down Syndrome but not in young Down Syndrome
Year: 2003
Type: article
Study design: Observational Study
Source: Neuroscience Letters
Institution: Pfizer (United States)
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2041934166
